Decoy TherapeuticsDCOY
13F holders, Q1 2026 (March 31)4holders
$6.53avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Decoy Therapeutics Inc. (DCOY) in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($7K), UBS Group AG ($4K) and Advisory Services Network, LLC ($268).
- Company
- Decoy Therapeutics Inc.
- CUSIP
- 79400X602
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $11K |
| Exits | 0 | $0 |
Ownership 4 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,021 | $7K |
| UBS Group AG | 0.00% | New | 546 | $4K |
| Advisory Services Network, LLC | 0.00% | New | 41 | $268 |
| Morgan Stanley | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is DCOY's weight in each manager's 13F, not the share of Decoy Therapeutics Inc. the manager owns.